AtriCure officer plans sale of 4,519 shares
The prior three-month sales listed for the officer were 3,657 shares for $201,135.00 and 7,763 shares for $407,557.50.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AtriCure, Inc. (ATRC) officer Salvatore Privitera gave notice of a proposed sale of 4,519 common shares, with an aggregate market value of $271,140.00. The approximate sale date is September 23, 2026, through Morgan Stanley Smith Barney LLC. The notice also lists Privitera sales during the prior three months: 3,657 common shares for $201,135.00 on September 8, 2026, and 7,763 common shares for $407,557.50 on September 2, 2026.
Key Figures
Key Terms
Rule 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.